The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors

The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle to the prospect of ICI treatment. IrAEs are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Xiao-Hui, Geng, Lu-Ying, Jiang, Pan-Pan, Xu, Hong, Nan, Ke-Jun, Yao, Yu, Jiang, Li-Li, Sun, Hong, Qin, Tian-Jie, Guo, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734811/
https://www.ncbi.nlm.nih.gov/pubmed/33317597
http://dx.doi.org/10.1186/s13046-020-01749-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734811/
https://www.ncbi.nlm.nih.gov/pubmed/33317597
http://dx.doi.org/10.1186/s13046-020-01749-x

Ejemplares similares